<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p217" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_217{left:411px;top:233px;letter-spacing:-0.1px;}
#t2_217{left:411px;top:78px;letter-spacing:-0.3px;}
#t3_217{left:413px;top:630px;}
#t4_217{left:70px;top:64px;}
#t5_217{left:70px;top:76px;}
#t6_217{left:143px;top:70px;}
#t7_217{left:206px;top:58px;}
#t8_217{left:206px;top:70px;}
#t9_217{left:206px;top:82px;}
#ta_217{left:298px;top:46px;}
#tb_217{left:298px;top:58px;}
#tc_217{left:298px;top:70px;}
#td_217{left:298px;top:82px;}
#te_217{left:298px;top:95px;}
#tf_217{left:70px;top:122px;}
#tg_217{left:70px;top:135px;}
#th_217{left:70px;top:147px;}
#ti_217{left:70px;top:159px;}
#tj_217{left:70px;top:171px;}
#tk_217{left:70px;top:183px;}
#tl_217{left:143px;top:122px;}
#tm_217{left:143px;top:135px;}
#tn_217{left:143px;top:147px;}
#to_217{left:143px;top:159px;}
#tp_217{left:143px;top:171px;}
#tq_217{left:143px;top:183px;}
#tr_217{left:206px;top:110px;}
#ts_217{left:206px;top:122px;}
#tt_217{left:206px;top:135px;}
#tu_217{left:206px;top:147px;}
#tv_217{left:206px;top:159px;}
#tw_217{left:206px;top:171px;}
#tx_217{left:206px;top:183px;}
#ty_217{left:206px;top:196px;}
#tz_217{left:298px;top:120px;}
#t10_217{left:298px;top:132px;}
#t11_217{left:298px;top:144px;}
#t12_217{left:298px;top:156px;}
#t13_217{left:298px;top:168px;}
#t14_217{left:298px;top:181px;}
#t15_217{left:298px;top:193px;}
#t16_217{left:298px;top:205px;}
#t17_217{left:298px;top:217px;}
#t18_217{left:298px;top:230px;}
#t19_217{left:298px;top:242px;}
#t1a_217{left:298px;top:254px;}
#t1b_217{left:298px;top:266px;}
#t1c_217{left:298px;top:278px;}
#t1d_217{left:298px;top:291px;}
#t1e_217{left:298px;top:303px;}
#t1f_217{left:298px;top:315px;}
#t1g_217{left:298px;top:327px;}
#t1h_217{left:298px;top:340px;}
#t1i_217{left:298px;top:352px;}
#t1j_217{left:298px;top:364px;}
#t1k_217{left:298px;top:376px;}
#t1l_217{left:298px;top:388px;}
#t1m_217{left:70px;top:248px;}
#t1n_217{left:70px;top:260px;}
#t1o_217{left:143px;top:236px;}
#t1p_217{left:143px;top:248px;}
#t1q_217{left:143px;top:260px;}
#t1r_217{left:143px;top:272px;}
#t1s_217{left:206px;top:211px;}
#t1t_217{left:206px;top:223px;}
#t1u_217{left:206px;top:236px;}
#t1v_217{left:206px;top:248px;}
#t1w_217{left:206px;top:260px;}
#t1x_217{left:206px;top:272px;}
#t1y_217{left:206px;top:284px;}
#t1z_217{left:206px;top:297px;}
#t20_217{left:70px;top:349px;}
#t21_217{left:70px;top:361px;}
#t22_217{left:143px;top:343px;}
#t23_217{left:143px;top:355px;}
#t24_217{left:143px;top:367px;}
#t25_217{left:206px;top:312px;}
#t26_217{left:206px;top:324px;}
#t27_217{left:206px;top:337px;}
#t28_217{left:206px;top:349px;}
#t29_217{left:206px;top:361px;}
#t2a_217{left:206px;top:373px;}
#t2b_217{left:206px;top:386px;}
#t2c_217{left:206px;top:398px;}
#t2d_217{left:70px;top:450px;}
#t2e_217{left:70px;top:462px;}
#t2f_217{left:70px;top:474px;}
#t2g_217{left:143px;top:438px;}
#t2h_217{left:143px;top:450px;}
#t2i_217{left:143px;top:462px;}
#t2j_217{left:143px;top:474px;}
#t2k_217{left:143px;top:487px;}
#t2l_217{left:206px;top:426px;}
#t2m_217{left:206px;top:438px;}
#t2n_217{left:206px;top:450px;}
#t2o_217{left:206px;top:462px;}
#t2p_217{left:206px;top:474px;}
#t2q_217{left:206px;top:487px;}
#t2r_217{left:206px;top:499px;}
#t2s_217{left:298px;top:413px;}
#t2t_217{left:298px;top:425px;}
#t2u_217{left:298px;top:438px;}
#t2v_217{left:298px;top:450px;}
#t2w_217{left:298px;top:462px;}
#t2x_217{left:298px;top:474px;}
#t2y_217{left:298px;top:487px;}
#t2z_217{left:298px;top:499px;}
#t30_217{left:298px;top:511px;}
#t31_217{left:70px;top:533px;}
#t32_217{left:70px;top:545px;}
#t33_217{left:143px;top:533px;}
#t34_217{left:143px;top:545px;}
#t35_217{left:206px;top:527px;}
#t36_217{left:206px;top:539px;}
#t37_217{left:206px;top:551px;}
#t38_217{left:298px;top:533px;}
#t39_217{left:298px;top:545px;}
#t3a_217{left:65px;top:573px;letter-spacing:0.8px;word-spacing:-0.8px;}
#t3b_217{left:65px;top:594px;}
#t3c_217{left:86px;top:594px;letter-spacing:0.9px;word-spacing:-0.8px;}
#t3d_217{left:65px;top:605px;letter-spacing:1px;}

.s1_217{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_217{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_217{
	FONT-SIZE: 37.6px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_217{
	FONT-SIZE: 36.7px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s5_217{
	FONT-SIZE: 30.6px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s6_217{
	FONT-SIZE: 30.6px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.t.m0_217{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts217" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg217Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg217" style="-webkit-user-select: none;"><object width="433" height="649" data="217/217.svg" type="image/svg+xml" id="pdf217" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_217" class="t m0_217 s1_217">O Guia do Jovem Internista </div>
<div id="t2_217" class="t m0_217 s2_217">2016</div>
<div id="t3_217" class="t s3_217">215</div>
<div id="t4_217" class="t s4_217">Tofacitinib </div>
<div id="t5_217" class="t s4_217">[inibidor JAK]</div>
<div id="t6_217" class="t s4_217">5mg 2x/dia</div>
<div id="t7_217" class="t s4_217">Hepática, hipercoles-</div>
<div id="t8_217" class="t s4_217">terolémia, risco de </div>
<div id="t9_217" class="t s4_217">infecção.</div>
<div id="ta_217" class="t s4_217">Hemograma, perfil </div>
<div id="tb_217" class="t s4_217">hepático e renal, </div>
<div id="tc_217" class="t s4_217">imunoglobulinas (Ig’s). </div>
<div id="td_217" class="t s4_217">Disponível em poucos </div>
<div id="te_217" class="t s4_217">países.</div>
<div id="tf_217" class="t s4_217">Anti-TNF</div>
<div id="tg_217" class="t s4_217">[Adalimumab, </div>
<div id="th_217" class="t s4_217">Etanercept, </div>
<div id="ti_217" class="t s4_217">Infliximab, </div>
<div id="tj_217" class="t s4_217">Golimumab, </div>
<div id="tk_217" class="t s4_217">Certolizumab]</div>
<div id="tl_217" class="t s4_217">Administração </div>
<div id="tm_217" class="t s4_217">(sc) auto-ad-</div>
<div id="tn_217" class="t s4_217">ministrada.</div>
<div id="to_217" class="t s4_217">Semanal </div>
<div id="tp_217" class="t s4_217">ou cada 2 </div>
<div id="tq_217" class="t s4_217">semanas.</div>
<div id="tr_217" class="t s4_217">Reacção local da </div>
<div id="ts_217" class="t s4_217">injecção, alergia. </div>
<div id="tt_217" class="t s4_217">Infecção (inclusive </div>
<div id="tu_217" class="t s4_217">oportunista) e reacti-</div>
<div id="tv_217" class="t s4_217">vação de tuberculose. </div>
<div id="tw_217" class="t s4_217">Risco aumentado de </div>
<div id="tx_217" class="t s4_217">neoplasia e doenças </div>
<div id="ty_217" class="t s4_217">desmielinizantes.</div>
<div id="tz_217" class="t s4_217">Rx tórax, serologias </div>
<div id="t10_217" class="t s4_217">víricas e prova de </div>
<div id="t11_217" class="t s4_217">tuberculina/IGRA antes </div>
<div id="t12_217" class="t s4_217">de iniciar.</div>
<div id="t13_217" class="t s4_217">Hemograma, perfil </div>
<div id="t14_217" class="t s4_217">hepático e lipídico (so-</div>
<div id="t15_217" class="t s4_217">bretudo Tocilizumab).</div>
<div id="t16_217" class="t s4_217">Função respiratória </div>
<div id="t17_217" class="t s4_217">(Abatacept!) </div>
<div id="t18_217" class="t s4_217">Impossibilita admi-</div>
<div id="t19_217" class="t s4_217">nistração de vacinas </div>
<div id="t1a_217" class="t s4_217">vivas (BCG, VASPR </div>
<div id="t1b_217" class="t s4_217">– sarampo, papeira e </div>
<div id="t1c_217" class="t s4_217">rubéola, varicela, febre </div>
<div id="t1d_217" class="t s4_217">amarela e VAP oral – </div>
<div id="t1e_217" class="t s4_217">poliomielite).</div>
<div id="t1f_217" class="t s4_217">Recomendada vacina </div>
<div id="t1g_217" class="t s4_217">anti-pneumocócica </div>
<div id="t1h_217" class="t s4_217">(cada 5 anos) e influen-</div>
<div id="t1i_217" class="t s4_217">za (anual).</div>
<div id="t1j_217" class="t s4_217">Pode ser necessário </div>
<div id="t1k_217" class="t s4_217">suspender nas intercor-</div>
<div id="t1l_217" class="t s4_217">rências infecciosas.</div>
<div id="t1m_217" class="t s4_217">Abatacept </div>
<div id="t1n_217" class="t s4_217">[Anti-CTLA4]</div>
<div id="t1o_217" class="t s4_217">Injecção sc </div>
<div id="t1p_217" class="t s4_217">auto-adminis-</div>
<div id="t1q_217" class="t s4_217">trada cada 2-4 </div>
<div id="t1r_217" class="t s4_217">semanas.</div>
<div id="t1s_217" class="t s4_217">Reacção local, alergia. </div>
<div id="t1t_217" class="t s4_217">Citopenias. Infecção </div>
<div id="t1u_217" class="t s4_217">(inclusive oportunista) </div>
<div id="t1v_217" class="t s4_217">e reactivação de TB. </div>
<div id="t1w_217" class="t s4_217">Risco aumentado de </div>
<div id="t1x_217" class="t s4_217">neoplasia e doenças </div>
<div id="t1y_217" class="t s4_217">desmielinizantes. Eax-</div>
<div id="t1z_217" class="t s4_217">cerbação de DPOC.</div>
<div id="t20_217" class="t s4_217">Tocilizumab </div>
<div id="t21_217" class="t s4_217">[Anti-IL6R]</div>
<div id="t22_217" class="t s4_217">Endovenoso </div>
<div id="t23_217" class="t s4_217">cada 4 </div>
<div id="t24_217" class="t s4_217">semanas.</div>
<div id="t25_217" class="t s4_217">Hepática, citopenias, </div>
<div id="t26_217" class="t s4_217">hipercolesterolémia, </div>
<div id="t27_217" class="t s4_217">rash. Infecção (in-</div>
<div id="t28_217" class="t s4_217">clusive oportunista) </div>
<div id="t29_217" class="t s4_217">e reactivação de TB. </div>
<div id="t2a_217" class="t s4_217">Risco aumentado de </div>
<div id="t2b_217" class="t s4_217">neoplasia e doenças </div>
<div id="t2c_217" class="t s4_217">desmielinizantes. </div>
<div id="t2d_217" class="t s4_217">Rituximab [Anti-</div>
<div id="t2e_217" class="t s4_217">CD20 – deplec-</div>
<div id="t2f_217" class="t s4_217">ção de células B]</div>
<div id="t2g_217" class="t s4_217">Endovenoso, </div>
<div id="t2h_217" class="t s4_217">cada 6 meses </div>
<div id="t2i_217" class="t s4_217">ou conforme </div>
<div id="t2j_217" class="t s4_217">duração da </div>
<div id="t2k_217" class="t s4_217">deplecção.</div>
<div id="t2l_217" class="t s4_217">Reacção local </div>
<div id="t2m_217" class="t s4_217">injecção, alergia, </div>
<div id="t2n_217" class="t s4_217">citopenias, hipo-</div>
<div id="t2o_217" class="t s4_217">gamaglobulinemia, </div>
<div id="t2p_217" class="t s4_217">reacções cutâneas, </div>
<div id="t2q_217" class="t s4_217">infecção (inclusive </div>
<div id="t2r_217" class="t s4_217">oportunista).</div>
<div id="t2s_217" class="t s4_217">Rx tórax, serologias </div>
<div id="t2t_217" class="t s4_217">víricas e prova de </div>
<div id="t2u_217" class="t s4_217">tuberculina/IGRA antes </div>
<div id="t2v_217" class="t s4_217">de iniciar.</div>
<div id="t2w_217" class="t s4_217">Hemograma no dia da </div>
<div id="t2x_217" class="t s4_217">perfusão.</div>
<div id="t2y_217" class="t s4_217">Níveis de CD19 ao 1º </div>
<div id="t2z_217" class="t s4_217">mês e cada 3 meses. </div>
<div id="t30_217" class="t s4_217">Ig’s cada 6 meses.</div>
<div id="t31_217" class="t s4_217">Anakinra [An-</div>
<div id="t32_217" class="t s4_217">ti-IL1]</div>
<div id="t33_217" class="t s4_217">100mg sc </div>
<div id="t34_217" class="t s4_217">diário.</div>
<div id="t35_217" class="t s4_217">Citopenias, risco de </div>
<div id="t36_217" class="t s4_217">infecção, reacção no </div>
<div id="t37_217" class="t s4_217">local.</div>
<div id="t38_217" class="t s4_217">Hemograma cada 3 </div>
<div id="t39_217" class="t s4_217">meses. </div>
<div id="t3a_217" class="t s5_217">*CTLA4 - inibe activação de céls T via de interacção com as céls apresentadoras de antigénio.</div>
<div id="t3b_217" class="t s6_217">NOTA:</div>
<div id="t3c_217" class="t s5_217">Apenas hidroxicloroquina, corticóide e azatioprina são considerados seguros na gravidez e </div>
<div id="t3d_217" class="t s5_217">amamentação.</div>

<!-- End text definitions -->


</div>
</body>
</html>
